Allianz Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-50,158	Closed	-$1.03M	–	2227
2023 Q3	$1.03M	Sell	50,158 -57,852	-54%	-$1.67M	﹤0.01%	1693
2023 Q2	$5.08M	Sell	108,010 -8,163	-7%	-$406K	0.01%	862
2023 Q1	$4.87M	Buy	116,173 +25,413	+28%	+$1.09M	0.01%	980
2022 Q4	$3.46M	Buy	90,760 +34,812	+62%	+$1.33M	0.01%	1072
2022 Q3	$2.19M	Buy	+55,948	New	+$2.16M	﹤0.01%	1202
2021 Q4	–	Sell	-75,768	Closed	-$3.36M	–	2672
2021 Q3	$3.36M	Buy	75,768 +37,590	+98%	+$1.72M	﹤0.01%	1448
2021 Q2	$2.17M	Sell	38,178 -12,730	-25%	-$900K	﹤0.01%	1448
2021 Q1	$3.81M	Buy	50,908 +38,168	+300%	+$3.13M	﹤0.01%	1166
2020 Q4	$1.1M	Buy	+12,740	New	+$939K	﹤0.01%	1461
2020 Q1	–	Sell	-27,995	Closed	-$2.02M	–	2712
2019 Q4	$2.02M	Sell	27,995 -97,024	-78%	-$11.9M	﹤0.01%	1870
2019 Q3	$17.6M	Sell	125,019 -10	-0%	-$1.67K	0.02%	831
2019 Q2	$22.9M	Buy	125,029 +12,460	+11%	+$2.13M	0.02%	754
2019 Q1	$17.9M	Buy	112,569 +87,665	+352%	+$12.7M	0.02%	804
2018 Q4	$2.34M	Sell	24,904 -13,082	-34%	-$1.5M	﹤0.01%	1709
2018 Q3	$5.37M	Hold	37,986	–	–	﹤0.01%	1531
2018 Q2	$5.95M	Sell	37,986 -6,488	-15%	-$1.02M	0.01%	1459
2018 Q1	$7.16M	Buy	44,474 +40,288	+962%	+$6.84M	0.01%	1388
2017 Q4	$689K	Sell	4,186 -3,468	-45%	-$336K	﹤0.01%	2341
2017 Q3	$477K	Buy	7,654 +3,076	+67%	+$242K	﹤0.01%	2429
2017 Q2	$365K	Sell	4,578 -3,088	-40%	-$223K	﹤0.01%	2476
2017 Q1	$545K	Buy	+7,666	New	+$449K	﹤0.01%	2386
2015 Q4	–	Sell	-138,145	Closed	-$5.85M	–	2499
2015 Q3	$5.85M	Buy	138,145 +83,720	+154%	+$5.16M	0.01%	1215
2015 Q2	$3.97M	Buy	+54,425	New	+$3.5M	﹤0.01%	1456